ID: ALA4646998

Max Phase: Preclinical

Molecular Formula: C29H27F2N5O

Molecular Weight: 499.57

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC[C@@H]1CN(C(c2ccc(F)cc2)c2ccc(F)cc2)CCN1c1cc(=O)n(C)c2ccc(C#N)nc12

Standard InChI:  InChI=1S/C29H27F2N5O/c1-3-24-18-35(29(19-4-8-21(30)9-5-19)20-6-10-22(31)11-7-20)14-15-36(24)26-16-27(37)34(2)25-13-12-23(17-32)33-28(25)26/h4-13,16,24,29H,3,14-15,18H2,1-2H3/t24-/m1/s1

Standard InChI Key:  PWULEVRIMGHKCO-XMMPIXPASA-N

Associated Targets(Human)

Diacylglycerol kinase alpha 73 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Diacylglycerol kinase zeta 13 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Diacylglycerol kinase alpha/zeta 14 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 499.57Molecular Weight (Monoisotopic): 499.2184AlogP: 4.77#Rotatable Bonds: 5
Polar Surface Area: 65.16Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.88CX LogP: 4.88CX LogD: 4.76
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.40Np Likeness Score: -1.01

References

1. Abdel-Magid AF..  (2020)  Cancer Immunotherapy through the Inhibition of Diacylglycerol Kinases Alpha and Zeta.,  11  (6): [PMID:32550982] [10.1021/acsmedchemlett.0c00118]

Source